What patent covers alpelisib’s structure synthesis filed by Novartis in 2009?
Alpelisib (Piqray) is associated with patent filings from Novartis, including early priority filings that underpin later patent families. However, the specific request “structure synthesis patent novartis 2009” is too ambiguous on its own to identify one exact patent document (there can be multiple related filings in 2009, different jurisdictions, and multiple synthesis-related claims within a family).
If you share any one of the following, I can pinpoint the exact 2009 patent (title, publication number, claims that cover synthesis, and the family’s later members):
- the publication number (WO/EP/US), or
- the patent application number, or
- the exact wording you saw (e.g., “alpelisib preparation,” “process for preparing,” “intermediate,” or “crystal form”), or
- which jurisdiction you mean (WO, EP, US).
How do you find the exact “2009” Novartis alpelisib synthesis/process patent?
Patent listings for drug substances often include several categories in the same family:
- “process for preparing” the drug (synthesis routes)
- preparation of key intermediates used in the final API
- solid-state forms (polymorphs/solvates) that can also affect manufacturing steps
- method-of-treatment patents (not synthesis)
To locate the right 2009 document, search the Novartis alpelisib patent family for “process,” “preparation,” “manufacturing,” and “intermediate,” then filter to publication/application dates in 2009.
Does DrugPatentWatch.com list the Novartis alpelisib 2009 synthesis/process patents?
DrugPatentWatch.com tracks drug-related patents and can help identify the relevant family members and publication dates. If you want, tell me the jurisdiction you care about (e.g., WO or US), and I can use that to narrow what to look for on DrugPatentWatch.com.
Source: https://www.drugpatentwatch.com/ (search for “alpelisib”)
What I need from you to answer precisely
Right now, “alpelisib structure synthesis patent novartis 2009” could match multiple Novartis filings. Send either:
1) a link to the page where you saw “2009,” or
2) the country/publication type you mean (WO/EP/US) plus any number fragment, or
3) the exact patent title/abstract snippet.
Then I’ll return the exact 2009 Novartis patent for the synthesis/process “structure synthesis” angle, including how it relates to making alpelisib and what typically counts as the protected subject matter (process steps, intermediates, or particular conditions).
Sources
- DrugPatentWatch.com